SEC Company Response from Viatris Inc (VTRS) (CIK 0001792044) (VTRS) — Feb 11, 2020
Viatris Inc (VTRS) (CIK 0001792044)
Date: Feb. 11, 2020 · CIK: 0001792044 · Accession: 0001193125-20-031417
AI Filing Summary & Sentiment
File numbers found in text: 333-234337
Letter
Acceleration Request
Upjohn Inc.
235 East 42nd Street
New York, NY
February 11, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549
Attention:
Franklin Wyman
Kevin W. Vaughn
Joseph McCann
Celeste Murphy
Re:
Upjohn Inc.
Registration Statement on Form S-4 (File No. 333-234337)
Request for Acceleration
Ladies and Gentlemen:
Reference is made to the Registration Statement on Form S-4 (File No. 333-234337) (the “Registration Statement”) filed by Upjohn Inc. (the “Company”) with the U.S. Securities and Exchange Commission (the “Commission”) on October 25, 2019, as amended on December 13, 2019, January 21, 2020 and February 6, 2020.
The Company hereby requests that the Registration Statement be made effective at 4:00 p.m. Eastern Time on February 13, 2020, or as soon as possible thereafter, in accordance with Rule 461 of the General Rules and Regulations promulgated under the U.S. Securities Exchange Act of 1933, as amended.
Please contact David K. Lam of Wachtell, Lipton, Rosen & Katz at (212) 403-1394 or by email at DKLam@wlrk.com or Gordon S. Moodie of Wachtell, Lipton, Rosen & Katz at (212) 403-1180 or by email at GSMoodie@wlrk.com with any questions you may have concerning this request. Please notify Mr. Lam or Mr. Moodie when this request for acceleration has been granted.
UPJOHN INC.
By:
/s/ Michael Goettler
Name:
Michael Goettler
Title:
President
cc: Doug Lankler, Pfizer Inc.
Bryan Supran, Pfizer Inc.
David K. Lam, Wachtell, Lipton, Rosen & Katz
Gordon S. Moodie, Wachtell, Lipton, Rosen & Katz
Bryan Roman, Mylan N.V.
Mark I. Greene, Cravath, Swaine & Moore LLP
Thomas E. Dunn, Cravath, Swaine & Moore LLP
Aaron M. Gruber, Cravath, Swaine & Moore LLP
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Upjohn Inc. 235 East 42nd Street New York, NY 10017 February 11, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attention: Franklin Wyman Kevin W. Vaughn Joseph McCann Celeste Murphy Re: Upjohn Inc. Registration Statement on Form S-4 (File No. 333-234337) Request for Acceleration Ladies and Gentlemen: Reference is made to the Registration Statement on Form S-4 (File No. 333-234337) (the “Registration Statement”) filed by Upjohn Inc. (the “Company”) with the U.S. Securities and Exchange Commission (the “Commission”) on October 25, 2019, as amended on December 13, 2019, January 21, 2020 and February 6, 2020. The Company hereby requests that the Registration Statement be made effective at 4:00 p.m. Eastern Time on February 13, 2020, or as soon as possible thereafter, in accordance with Rule 461 of the General Rules and Regulations promulgated under the U.S. Securities Exchange Act of 1933, as amended. Please contact David K. Lam of Wachtell, Lipton, Rosen & Katz at (212) 403-1394 or by email at DKLam@wlrk.com or Gordon S. Moodie of Wachtell, Lipton, Rosen & Katz at (212) 403-1180 or by email at GSMoodie@wlrk.com with any questions you may have concerning this request. Please notify Mr. Lam or Mr. Moodie when this request for acceleration has been granted. UPJOHN INC. By: /s/ Michael Goettler Name: Michael Goettler Title: President cc: Doug Lankler, Pfizer Inc. Bryan Supran, Pfizer Inc. David K. Lam, Wachtell, Lipton, Rosen & Katz Gordon S. Moodie, Wachtell, Lipton, Rosen & Katz Bryan Roman, Mylan N.V. Mark I. Greene, Cravath, Swaine & Moore LLP Thomas E. Dunn, Cravath, Swaine & Moore LLP Aaron M. Gruber, Cravath, Swaine & Moore LLP